Our mission
Discover, develop, and commercialize a new class of RNA therapies informed by human genetics and disease biology to improve the lives of patients with debilitating and life-threatening diseases.
Our vision
Create transformative genetic medicines for diseases with high prevalence.
Meet our team
Read More >
Ram Aiyar, Ph.D., MBA
Chief Executive Officer & President
Read More >
Loic Vincent, Ph.D.
Chief Scientific Officer
Read More >
Todd Chappell, MBA
Chief Operating Officer
Read More >
Jeffrey M. Cerio, Pharm.D., J.D.
SVP, General Counsel
Read More >
Stephanie Engels
Chief People Officer
Read More >
Gaozhong Zhu, Ph.D.
SVP, CMC & Technical Operations